Genotypic tropism testing in proviral DNA to guide maraviroc initiation in aviremic subjects: 48-week analysis of the PROTEST study

INTRODUCTION: In a previous interim 24-week virological safety analysis of the PROTEST study [1], initiation of Maraviroc (MVC) plus 2 nucleoside reverse-transcriptase inhibitors (NRTIs) in aviremic subjects based on genotypic tropism testing of proviral HIV-1 DNA was associated with low rates of vi...

Descripción completa

Detalles Bibliográficos
Autores principales: Garcia, Federico, Poveda, Eva, Jesús Pérez-Elías, Maria, Hernández Quero, José, Àngels Ribas, Maria, Martínez-Madrid, Onofre J, Flores, Juan, Crespo, Manel, Gutiérrez, Félix, García-Deltoro, Miguel, Imaz, Arkaitz, Ocampo, Antonio, Artero, Arturo, Blanco, Francisco, Bernal, Enrique, Pasquau, Juan, Mínguez-Gallego, Carlos, Pérez, Núria, Aiestarán, Aintzane, Paredes, Roger
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International AIDS Society 2014
Materias:
Oral Presentation – Abstract O334
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4224842/
https://www.ncbi.nlm.nih.gov/pubmed/25394029
http://dx.doi.org/10.7448/IAS.17.4.19520

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4224842/
https://www.ncbi.nlm.nih.gov/pubmed/25394029
http://dx.doi.org/10.7448/IAS.17.4.19520

Ejemplares similares